genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2017
Uterine fibroids
Industry News
Allergan, Gedeon Richter Plan 2017 FDA Filing for Uterine Fibroids Drug Ulipristal
News
Watson Gains Rights to PregLem’s Uterine Fibroid Drug for $17M
News
PregLem Reports Phase III Success for Uterine Fibroids Therapy
Cancer
Invida to Commercialize Three Ipsen Drugs in Asia Pacific Countries
Cancer
Nine European Countries Sanction Six-Month Formulation of Debiopharm’s Prostate Cancer Medication
News
Repros Ceases All Clinical Studies in Endometriosis due to Increased Liver Enzyme Levels
Cancer
Repros Gets an Extension from NIH for Deadlines Related to Lead Anticancer Agent
Scroll Up
Scroll Up
